x

Join Advarra

Learn more about our company team, careers, and values. Join Advarra’s Talented team to take on engaging work in a dynamic environment.

See Jobs

 
News

Bloomberg Law Features Advarra Chief Compliance Officer on New Ethics for Fitbit Data

Advarra Chief Compliance Officer and Institutional Official Michele Russell Einhorn was recently featured in Bloomberg Law on Your Fitbit Data Means New Ethics Conundrums for Clinical Trials.

Read Now
Read more
 
Blog

Compensating Clinical Trial Participants: The Basics

Participant compensation is often a complicated matter. This blog will shed light on what an IRB considers during its review.

Read Now
5 min. read
Read more
 
Blog

What Is a Screening Consent?

Study-specific screening consent is a subtype of informed consent, which ensures a research participant understands of the research and its risks.

Read Now
3 min. read
Read more
 
Webinar

Making Mobile Clinical Trials a Reality

In this webinar hosted by Advarra, presenters will share findings, recommendations, and resources from four projects in CTTI’s MCT program: Novel Endpoints, Mobile Technologies, Decentralized Trials, and Stakeholder Perceptions.

Watch Now
Read more
 
Blog

Quality Improvement Project vs Human Subject Research: What’s the Difference?

Quality improvement and human subjects research often intersect. Executive IRB Chair Sara Harnish discusses questions to differentiate the two.

Read Now
3 min. read
Read more
 
Blog

The Future of Phase I Oncology Studies

Oncology drugs in phase I trials are usually conducted on patients with cancer due to their inherent risk. Advarra IRB member Ran Goldman expands:

Read Now
4 min. read
Read more
 
Blog

Meeting the Challenges of Investigator-Initiated Trials

How does investigator-initiated research differ from other types of clinical research? Advarra IRB Chairperson Robert Romanchuk explains.

Read Now
6 min. read
Read more
 
Webinar

How to Engage Your IRB to Improve Clinical Trial Risk Management

We will discuss real-world examples of how IRBs can further improve risk management and quality systems through education of all aspects in clinical trials.

Watch Now
Read more
 
Blog

The Challenge of Unproven Regenerative Stem Cell Therapies

Stem cell clinics with unproven treatments are on the rise in the US. Learn how the FDA is working to bring new stem cell therapies under federal oversight.

Read Now
7 min. read
Read more
 
Blog

Can Ethics Review Catch Up to the CBD Craze?

CBD, a non-psychoactive cannabinoid, is experiencing a massive surge in popularity, but clinical research lags behind in verifying effective uses.

Read Now
4 min. read
Read more
 
Blog

Quorum/Kinetiq Acquisition & Integration:
What You Need to Know

On March 5, 2019, Advarra announced its acquisition of Quorum Review IRB and Kinetiq, the research and technology consulting division of Quorum.

Read Now
Read more
 
Info Sheet

Revised Common Rule Quick Reference

March 1, 2019

Most requirements for the revised Common Rule, the federal policy for the protection of human subjects in research, went into effect on January 21, 2019. This reference will help you: ...

Read Now
Read more